Northera 100 MG capsule 90S
Ended Awarded
- Contract number
- SPE2DR26FJPS2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,821
Award facts
- Contract value 100% obligated
- $2,821.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency has awarded a firm fixed-price delivery order valued at $2,821.24 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Northera 100 mg capsules (90 count). This delivery order, issued on November 17, 2025, with an ultimate completion date of December 9, 2025, represents no set-aside utilization and was issued without geographic or socioeconomic restrictions. DMS Pharmaceutical Group will perform work at its facility in Park Ridge, Illinois. The award is issued under the company's single-award Indefinite Delivery Contract (IDC) designated SPE2DR, which was established under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative on November 13, 2025.
The underlying PPV-G GEN V contract, valued at $499,999,999 with a completion date of December 31, 2036, positions DMS Pharmaceutical Group as a critical pharmaceutical supplier within the Department of Defense's global military healthcare supply chain. As part of a broader $30.3 billion federal acquisition strategy, the PPV-G GEN V program authorizes the Defense Logistics Agency to issue delivery orders for comprehensive pharmaceutical products including branded and generic prescription medications, over-the-counter drugs, biologics, and medical consumables to support recurring medical supply requirements across military healthcare facilities worldwide. DMS Pharmaceutical Group's demonstrated performance across numerous prior delivery orders and its competitive capabilities in unrestricted federal procurement validate its selection as a prime vendor contractor supporting Department of Defense healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FJPS2?
SPE2DR26FJPS2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DR26FJPS2 worth?
The government has obligated $2,821 on SPE2DR26FJPS2.
Is contract SPE2DR26FJPS2 an order under another contract?
Yes. SPE2DR26FJPS2 is a delivery order under SPE2DR25D9213, an indefinite delivery contract.
Was contract SPE2DR26FJPS2 competed?
The extent of competition for SPE2DR26FJPS2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award